0
USD
EUR USD GBP
+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Deferoxamine"

Following a topic allows Research and Markets to customize your experience and provide personalized recommendations.
From
EUR$3,545USDGBP
EUR$3,939USDGBP
From
EUR$6,499USDGBP
From
EUR$7,500USDGBP
From
EUR$4,500USDGBP
  • 7 Results (Page 1 of 1)
Loading Indicator

Deferoxamine is a hematological drug used to treat iron overload in patients with thalassemia, sickle cell anemia, and other conditions. It is an iron chelator, meaning it binds to iron in the body and helps remove it from the bloodstream. Deferoxamine is administered intravenously or subcutaneously, and is available in both generic and brand-name forms. Common side effects include nausea, vomiting, and headache. Deferoxamine is a widely used drug in the hematological market, and is often prescribed in combination with other drugs to treat iron overload. It is also used to treat acute iron poisoning, and is sometimes used off-label to treat other conditions such as lead poisoning. Companies in the deferoxamine market include Novartis, Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals. Show Less Read more